Cognitive behavior therapy boosts outcomes in depressed diabetes patients

11/1/2013 |

Data on patients with uncontrolled type 2 diabetes and depression revealed that those who underwent cognitive behavioral therapy for adherence and depression attained better A1C levels and exhibited greater adherence to oral medication and self-monitoring of blood glucose at four months compared with those in the Enhanced Treatment as Usual arm. The findings were published in Diabetes Care.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park